BioArctic, a Swedish biotechnology company renowned for its innovative approach to neurodegenerative diseases, has made significant strides in Alzheimer’s research. […]
Merck KGaA, Darmstadt, Germany, is reportedly in advanced negotiations to acquire U.S.-based biotech firm SpringWorks Therapeutics. This potential acquisition aims
Microcapillary technology, particularly light-based microcapillary monitoring, represents a significant advancement in biotechnology. These microcapillaries, with apertures ranging from 0.1 mm
Draupnir Bio, a cutting-edge biotechnology company, has successfully raised €12 million in equity investments to advance its innovative approach in
Novo Holdings has led a $100 million Series C financing round for Asceneuron, a Swiss biotech company. This funding aims
CatalYm, a German biotech company specializing in cancer immunotherapy, has recently secured $150 million in a Series D funding round.
The field of cancer treatment is on the cusp of a breakthrough with Myricx Bio’s innovative approach to antibody-drug conjugates
Eli Lilly and Company, a global leader in pharmaceutical development, has announced a significant acquisition of Morphic Holding, Inc., a
In a significant stride towards ethical biomedical advancements, Brisbane-based biotech company Gelomics has raised $2.2 million in a pre-seed funding
Alumis, a clinical-stage immunology biotech company, has priced its downsized initial public offering (IPO) at $16 per share, at the
